Fortis Health.

65
Hold
  • Market Cap: Mid Cap
  • Industry: Hospital
  • ISIN: INE061F01013
  • NSEID: FORTIS
  • BSEID: 532843
INR
886.00
-2.05 (-0.23%)
BSENSE

Dec 05

BSE+NSE Vol: 19.17 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Consolidated - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
No of Months
12
12
12
12
12
12
Operating Income
7,782.00
6,892.00
6,297.00
5,717.00
4,030.00
4,632.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
7,782.00
6,892.00
6,297.00
5,717.00
4,030.00
4,632.00
Expenditure (Ex Depriciation)
Stock Adjustments
-7.00
15.00
0.00
-46.00
1.00
-21.00
Raw Materials Consumed
1,838.00
1,603.00
1,454.00
1,403.00
974.00
985.00
Power & Fuel Cost
123.00
119.00
119.00
111.00
102.00
104.00
Employee Cost
1,167.00
1,119.00
1,046.00
972.00
849.00
916.00
Operating Expenses
2,161.00
1,963.00
1,792.00
1,538.00
387.00
441.00
General and Administration Expenses
-1.00
-1.00
-1.00
-1.00
-1.00
-1.00
Selling and Distribution Expenses
342.00
270.00
231.00
161.00
85.00
194.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
102.00
82.00
86.00
74.00
93.00
92.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
6,194.00
5,625.00
5,196.00
4,648.00
3,625.00
4,022.00
Operating Profit (PBDIT) excl Other Income
1,587.00
1,267.00
1,101.00
1,068.00
404.00
609.00
Other Income
66.00
38.00
61.00
27.00
46.00
52.00
Operating Profit (PBDIT)
1,654.00
1,305.00
1,163.00
1,096.00
451.00
662.00
Interest
184.00
130.00
129.00
146.00
165.00
205.00
Profit before Depriciation and Tax
1,470.00
1,174.00
1,033.00
949.00
285.00
457.00
Depreciation
385.00
342.00
315.00
300.00
290.00
291.00
Profit Before Taxation & Exceptional Items
1,084.00
832.00
718.00
648.00
-5.00
165.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
1,007.00
857.00
813.00
987.00
43.00
239.00
Provision for Tax
197.00
212.00
180.00
197.00
99.00
147.00
Profit After Tax
797.00
635.00
611.00
765.00
-103.00
79.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
-596.00
-1,014.00
-2,078.00
-2,184.00
-1,639.00
-1,695.00
Profit Available for appropriations
177.00
-415.00
-1,489.00
-1,629.00
-1,749.00
-1,637.00
Appropriations
177.00
-415.00
-1,489.00
-1,629.00
-1,749.00
-1,637.00
Equity Dividend (%)
10.00%
10.00%
10.00%
0.00%
0.00%
0.00%
Earnings Per Share
10.26
7.93
7.80
7.35
-1.45
0.77
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 12.91% vs 9.45% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 25.27% vs 15.10% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 40.83% vs 1.44% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is 25.51% vs 4.02% in Mar 2024

Compare Profit and Loss Results of Fortis Health.
Markets Mojo
Figures in Cr
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
7,782.00
21,794.00
-14,012.00
-64.29%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
7,782.00
21,794.00
-14,012.00
-64.29%
Expenditure (Ex Depriciation)
Stock Adjustments
-7.00
-1.00
-6.00
-600.00%
Raw Materials Consumed
1,838.00
11,311.00
-9,473.00
-83.75%
Power & Fuel Cost
123.00
266.00
-143.00
-53.76%
Employee Cost
1,167.00
2,769.00
-1,602.00
-57.85%
Operating Expenses
2,161.00
2,396.00
-235.00
-9.81%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
342.00
531.00
-189.00
-35.59%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
102.00
188.00
-86.00
-45.74%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
6,194.00
18,772.00
-12,578.00
-67.00%
Operating Profit (PBDIT) excl Other Income
1,587.00
3,021.00
-1,434.00
-47.47%
Other Income
66.00
200.00
-134.00
-67.00%
Operating Profit (PBDIT)
1,654.00
3,222.00
-1,568.00
-48.67%
Interest
184.00
458.00
-274.00
-59.83%
Profit before Depriciation and Tax
1,470.00
2,763.00
-1,293.00
-46.80%
Depreciation
385.00
757.00
-372.00
-49.14%
Profit Before Taxation & Exceptional Items
1,084.00
2,006.00
-922.00
-45.96%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
1,007.00
2,039.00
-1,032.00
-50.61%
Provision for Tax
197.00
534.00
-337.00
-63.11%
Profit After Tax
797.00
1,472.00
-675.00
-45.86%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
-596.00
2,772.00
-3,368.00
-121.50%
Profit Available for appropriations
177.00
4,218.00
-4,041.00
-95.80%
Appropriations
177.00
4,218.00
-4,041.00
-95.80%
Equity Dividend (%)
10%
253.2%
-243.20
Earnings Per Share
10.26
100.56
-90.30
-89.80%
Profit And Loss - Net Sales
Net Sales 7,782.75 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 12.91% vs 9.45% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 1,587.95 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 25.27% vs 15.10% in Mar 2024

Profit And Loss - Interest
Interest 184.41 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 40.83% vs 1.44% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 797.86 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 25.51% vs 4.02% in Mar 2024